CDKN2B-AS1 and retinoblastoma: Other studies in this regard, have also demonstrated the role of lncRNA ANRIL in resistance to chemotherapeutic medications, including the role of lncRNA ANRIL in cisplatin-resistance in retinoblastoma cells via the ATP-binding cassette transporter G2 (ABCG) expression pathway [35].